Rankings
▼
Calendar
REVB FY 2020 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
REVB
Revelation Biosciences, Inc.
$2M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$2M
EPS (Diluted)
$-9032.69
Cash Flow
Operating Cash Flow
-$215,074
Free Cash Flow
-$215,070
Stock-Based Comp.
$43,848
Balance Sheet
Total Assets
$5M
Total Liabilities
$1M
Stockholders' Equity
$3M
Cash & Equivalents
$4M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$4M
-$3,638
-104238.1%
Net Income
-$2M
-$3,638
-44718.6%
← Q4 2019
All Quarters
Q1 2020 →